Michigan startup Atterocor raises $16 million for adrenal cancer therapy
This article was originally published in Scrip
Executive Summary
Ann Arbor, Michigan-based startup Atterocor benefitted from recent increased interest in health care venture capital investment in the Midwestern US with a $16 million Series A financing round to kickstart the company focused on therapies for adrenal cancer.